Editors' note: This article discusses one or more penny stocks and/or microcaps. Such stocks are easily manipulated; do your own careful due diligence.

The munKNEE.com Pure-Play Pot Stock Index collapsed this past week (-1.5%) compared to the previous week (+25.1%) with 17 of the 25 constituents declining, 5 advancing and 3 having No Change in price.
Index Performance
The Index has companies doing business in a number of different categories and sub-categories based on their primary area of focus in the cannabis industry. These categories are identified below along with those stocks within each category that changed price by 10% or more:
- The Vertically Integrated (i.e. Seed-to-Sale) Category went down 1.8%. The category consists of 22 index constituents that grow, process, and sell cannabis and hemp flower and related products.
- The Canadian Licensed Producer (LPs) Sub-Category went down 7.5% (up 42.1% the previous week). 3 of the 7 index constituents within the category changed prices by 10% or more, namely:
- The non-hemp U.S. Multi-State Operator (MSOs) Sub-Category went up 0.9% vs. +17.3% the previous week. Only 2 of the 13 index constituents changed price by 10% or more, namely:
- The Hemp Seed-to-Sale MSO Sub-Category went up 10.8% vs. +39.0% the previous week but neither of the 2 index constituents in the category changed price by 10% or more.
- The Extraction Category went up 2.7% vs. +7.0% the previous week, This category focuses on the extraction of cannabis compounds and their infusion into consumer products, and one of the 2 index constituents within the category changed price by 10% or more, namely,
- Valens (VLNCF) +11.8% vs. +11.5% the previous week.
- The Consumption Devices Category went down 12.2% vs. +28.0% the previous week. This category has only one index constituent (Greenlane (GNLN) focused on developing and selling personal consumption devices for cannabis consumers, such as vape pens and inhalers.
*Please note: The 25 pure-play stocks in the munKNEE.com Pure-Play Pot Stock Index are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products and, as such, the Index reflects the true health of the marijuana industry in the U.S. and Canada. In addition, the Index only includes those pure-play cannabis stocks that consistently trade for more than US$1/share.


.webp)
Comments
Log in or sign up to join the conversation.